Applicant, as named in the Orange Book

Amneal

Next listed expiry: Ongentys on 12 Dec 2032. 3 products with live protection, 4 without.

Products with listed protection

Drug	Ingredient	NDA	Earliest generic entry	Basis
Ongentys · 2 strengths opicapone	opicapone	212489	12 Dec 2032	patent
Brekiya (Autoinjector) dihydroergotamine mesylate	dihydroergotamine mesylate	215400	24 Aug 2039	patent
Potassium Phosphates In 0.9% Sodium Chloride potassium phosphate, dibasic; potassium phosphate, monobasic	potassium phosphate, dibasic; potassium phosphate, monobasic	218343	12 Oct 2041	patent

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.

Products without listed protection (4)

Drug	Ingredient	NDA	Earliest generic entry	Basis
Activella estradiol; norethindrone acetate	estradiol; norethindrone acetate	020907	open now	no listed protection
Lioresal · 3 strengths baclofen	baclofen	020075	open now	no listed protection
Sodium Bicarbonate sodium bicarbonate	sodium bicarbonate	220790	open now	no listed protection
Zomig · 2 strengths zolmitriptan	zolmitriptan	021450	open now	no listed protection